[EN] SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5<br/>[FR] INHIBITEURS SÉLECTIFS DE LA PROTÉINE ARGININE MÉTHYLTRANSFÉRASE 5
申请人:PRELUDE THERAPEUTICS INC
公开号:WO2020206308A1
公开(公告)日:2020-10-08
The disclosure is directed to methods of treating disease using compounds of Formula I, Formula II, Formula III, Formula IV, Formula V, or Formula VI:
披露的内容涉及使用以下化合物治疗疾病的方法:Formula I、Formula II、Formula III、Formula IV、Formula V或Formula VI。